Barclays’s Conformis, Inc. Common Stock CFMS Stock Holding History

Barclays’s Portfolio CFMS Stock Details CFMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-600	Closed	-$78K	–	7045
2017 Q1	$78K	Hold	600	–	–	﹤0.01%	5067
2016 Q4	$122K	Buy	+600	New	+$133K	﹤0.01%	4608

Other funds holding CFMS

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Barclays's CFMS Position: Q3 2021 in Review

Barclays sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2021, closing a stake of 6,227 shares — an estimated $179K sold.

Barclays first reported a position in CFMS in Q2 2016 and held it in 18 quarters. The position peaked at $358K in Q2 2019. 80 funds tracked by Wall St. Rank hold CFMS as of Q3 2021.

Barclays reported no remaining Conformis, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Barclays sold 6,227 Conformis, Inc. Common Stock shares in Q3 2021, an estimated $179K.
Barclays first reported a position in Conformis, Inc. Common Stock in Q2 2016 and held it in 18 quarters.
Barclays's Conformis, Inc. Common Stock position peaked at $358K in Q2 2019.
80 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2021.

Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.